cardiology careers collections past issues search home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 3


Figure 3 CRP Induction of NF-{kappa}B Activation in Circulating Monocytes as Assessed by EMSA (Protocol B)

In 8 healthy volunteers, aliquots of 5 x 105 cells were incubated at 37°C in PBS and stimulated with increasing doses of recombinant human (rh) CRP (5 to 10 to 25 µg/ml) for 30 min to assess the effects on NF-{kappa}B activation. A cell aliquot was incubated with the NF-{kappa}B inhibitor pyrrolidine dithiocarbamate (PDTC) (50 mmol/l) for 1 h before CRP stimulation (25 µg/ml), and another cell aliquot was stimulated with CRP (25 µg/ml) denatured by incubation in boiling water bath for 1 h (25den). As a positive control (Pos) nuclear extracts were generated from 5 x 105 monocytes incubated for 30 min with 10 ng/ml LPS, and as a negative control (Neg) nuclear extracts were generated from 5 x 105 monocytes incubated for 30 min with PBS only. As shown in this representative EMSA, NF-{kappa}B activation in circulating monocytes was induced by stimulation with increasing doses of rhCRP and inhibited by preincubation with PDTC (50 mmol/l) and by the use of denatured rhCRP (A); coincubation of both rhCRP and LPS had a greater-than-additive effect (B). Gel supershift experiments with monoclonal antibodies to the p50 subunit indicated that complexes consisted of heterodimers containing the p50 subunit. Other abbreviations as in Figures 1 and 2.





Right arrow Return to article

 
  cardiology careers collections past issues search home